{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:03:50Z","timestamp":1787022230088,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1378\/chest.11-2521","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T02:16:35Z","timestamp":1328580995000},"page":"500-505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Advancing Cardiovascular Research"],"prefix":"10.1016","volume":"141","author":[{"given":"Michael S.","family":"Lauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1378\/chest.11-2521_bib1","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1056\/NEJMsa054744","article-title":"The value of medical spending in the United States, 1960-2000","volume":"355","author":"Cutler","year":"2006","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1378\/chest.11-2521_bib2","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa0908610","article-title":"Population trends in the incidence and outcomes of acute myocardial infarction","volume":"362","author":"Yeh","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1378\/chest.11-2521_bib3","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med"},{"issue":"5961","key":"10.1378\/chest.11-2521_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1126\/science.1185055","article-title":"Research agenda. Opportunities for research and NIH","volume":"327","author":"Collins","year":"2010","journal-title":"Science"},{"issue":"5","key":"10.1378\/chest.11-2521_bib5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jcin.2010.12.016","article-title":"Emerging genomic applications in coronary artery disease","volume":"4","author":"Damani","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1378\/chest.11-2521_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/jama.299.3.296","article-title":"Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension","volume":"299","author":"Lynch","year":"2008","journal-title":"JAMA"},{"issue":"17","key":"10.1378\/chest.11-2521_bib7","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1056\/NEJMra1003941","article-title":"Franklin H. Epstein Lecture. Cardiac development and implications for heart disease","volume":"363","author":"Epstein","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1378\/chest.11-2521_bib8","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCULATIONAHA.109.889048","article-title":"MicroRNAs add a new dimension to cardiovascular disease","volume":"121","author":"Small","year":"2010","journal-title":"Circulation"},{"issue":"6","key":"10.1378\/chest.11-2521_bib9","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrcardio.2009.56","article-title":"MicroRNAs and cardiac pathology","volume":"6","author":"Latronico","year":"2009","journal-title":"Nat Rev Cardiol"},{"issue":"18","key":"10.1378\/chest.11-2521_bib10","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa0707402","article-title":"Genetically elevated C-reactive protein and ischemic vascular disease","volume":"359","author":"Zacho","year":"2008","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1378\/chest.11-2521_bib11","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa0908679","article-title":"Patient-specific induced pluripotent stem-cell models for long-QT syndrome","volume":"363","author":"Moretti","year":"2010","journal-title":"N Engl J Med"},{"issue":"7341","key":"10.1378\/chest.11-2521_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"issue":"5830","key":"10.1378\/chest.11-2521_bib13","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.1142447","article-title":"A common allele on chromosome 9 associated with coronary heart disease","volume":"316","author":"McPherson","year":"2007","journal-title":"Science"},{"issue":"5830","key":"10.1378\/chest.11-2521_bib14","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1142842","article-title":"A common variant on chromosome 9p21 affects the risk of myocardial infarction","volume":"316","author":"Helgadottir","year":"2007","journal-title":"Science"},{"issue":"18","key":"10.1378\/chest.11-2521_bib15","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJMcibr1002359","article-title":"Chromosome 9p21 and coronary artery disease","volume":"362","author":"McPherson","year":"2010","journal-title":"N Engl J Med"},{"issue":"7287","key":"10.1378\/chest.11-2521_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature08801","article-title":"Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice","volume":"464","author":"Visel","year":"2010","journal-title":"Nature"},{"issue":"7333","key":"10.1378\/chest.11-2521_bib17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nature09753","article-title":"9p21 DNA variants associated with coronary artery disease impair interferon-\u03b3 signalling response","volume":"470","author":"Harismendy","year":"2011","journal-title":"Nature"},{"issue":"9753","key":"10.1378\/chest.11-2521_bib18","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Cholesterol Treatment Trialists' (CTT) Collaboration","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"10.1378\/chest.11-2521_bib19","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1378\/chest.11-2521_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa062418","article-title":"TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program","volume":"355","author":"Florez","year":"2006","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1378\/chest.11-2521_bib21","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMoa1008410","article-title":"Effects of CYP2C19 genotype on outcomes of clopidogrel treatment","volume":"363","author":"Par\u00e9","year":"2010","journal-title":"N Engl J Med"},{"issue":"5824","key":"10.1378\/chest.11-2521_bib22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1126\/science.1139089","article-title":"Control of stress-dependent cardiac growth and gene expression by a microRNA","volume":"316","author":"van Rooij","year":"2007","journal-title":"Science"},{"issue":"2","key":"10.1378\/chest.11-2521_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCRESAHA.110.227496","article-title":"The art of microRNA research","volume":"108","author":"van Rooij","year":"2011","journal-title":"Circ Res"},{"issue":"8","key":"10.1378\/chest.11-2521_bib24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jacc.2011.03.052","article-title":"The year in atherothrombosis","volume":"58","author":"Sanz","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"10.1378\/chest.11-2521_bib25","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"issue":"90","key":"10.1378\/chest.11-2521_bib26","doi-asserted-by":"crossref","first-page":"90cm17","DOI":"10.1126\/scitranslmed.3002747","article-title":"Reengineering translational science: the time is right","volume":"3","author":"Collins","year":"2011","journal-title":"Sci Transl Med"},{"issue":"7","key":"10.1378\/chest.11-2521_bib27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.109.917948","article-title":"Translational research for cardiovascular diseases at the National Heart, Lung, and Blood Institute: moving from bench to bedside and from bedside to community","volume":"121","author":"Lauer","year":"2010","journal-title":"Circulation"},{"issue":"12","key":"10.1378\/chest.11-2521_bib28","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJMp0808414","article-title":"An uncertain future for cardiovascular drug development?","volume":"360","author":"Garber","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1378\/chest.11-2521_bib29","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.cct.2011.05.003","article-title":"Oversight and management of a cell therapy clinical trial network: experience and lessons learned","volume":"32","author":"Moy\u00e9","year":"2011","journal-title":"Contemp Clin Trials"},{"issue":"4","key":"10.1378\/chest.11-2521_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/gme.0b013e3181f43404","article-title":"Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009","volume":"18","author":"Tsai","year":"2011","journal-title":"Menopause"},{"issue":"9","key":"10.1378\/chest.11-2521_bib31","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/CIRCULATIONAHA.111.044107","article-title":"Improvements in door-to-balloon time in the United States, 2005 to 2010","volume":"124","author":"Krumholz","year":"2011","journal-title":"Circulation"},{"issue":"23","key":"10.1378\/chest.11-2521_bib32","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","journal-title":"JAMA"},{"issue":"23","key":"10.1378\/chest.11-2521_bib33","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa066139","article-title":"Coronary intervention for persistent occlusion after myocardial infarction","volume":"355","author":"Hochman","year":"2006","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1378\/chest.11-2521_bib34","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archinternmed.2010.130","article-title":"Impact of the ALLHAT\/JNC7 Dissemination Project on thiazide-type diuretic use","volume":"170","author":"Stafford","year":"2010","journal-title":"Arch Intern Med"},{"issue":"18","key":"10.1378\/chest.11-2521_bib35","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/archinternmed.2011.315","article-title":"Impact of National Clinical Guideline Recommendations for Revascularization of Persistently Occluded Infarct-Related Arteries on Clinical Practice in the United States","volume":"171","author":"Deyell","year":"2011","journal-title":"Arch Intern Med"},{"issue":"37","key":"10.1378\/chest.11-2521_bib36","doi-asserted-by":"crossref","first-page":"37cm18","DOI":"10.1126\/scitranslmed.3001235","article-title":"Patient-Centered Outcomes Research Institute: the intersection of science and health care","volume":"2","author":"Clancy","year":"2010","journal-title":"Sci Transl Med"},{"issue":"23","key":"10.1378\/chest.11-2521_bib37","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1001\/jama.299.23.2789","article-title":"The perfect storm of overutilization","volume":"299","author":"Emanuel","year":"2008","journal-title":"JAMA"},{"issue":"17","key":"10.1378\/chest.11-2521_bib38","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/jama.2011.551","article-title":"Coronary revascularization trends in the United States, 2001-2008","volume":"305","author":"Epstein","year":"2011","journal-title":"JAMA"},{"issue":"25","key":"10.1378\/chest.11-2521_bib39","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1378\/chest.11-2521_bib40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/jama.2009.2029","article-title":"Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial","volume":"303","author":"Wilber","year":"2010","journal-title":"JAMA"},{"issue":"12","key":"10.1378\/chest.11-2521_bib41","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1378\/chest.11-2521_bib42","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"Smith","year":"2011","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1378\/chest.11-2521_bib43","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMhpr0808703","article-title":"Health insurers and medical-imaging policy\u2014a work in progress","volume":"360","author":"Iglehart","year":"2009","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1378\/chest.11-2521_bib44","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1006524","article-title":"Long-term effects of intensive glucose lowering on cardiovascular outcomes","volume":"364","author":"ACCORD Study Group;","year":"2011","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1378\/chest.11-2521_bib45","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"ACCORD Study Group;","year":"2010","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1378\/chest.11-2521_bib46","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"ACCORD Study Group;","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.11-2521_bib47","series-title":"Catheter ablation versus anti-arrhythmic drug therapy for atrial fibrillation trial (CABANA). NCT00911508","author":"National Institutes of Health Clinical Center","year":"2009"},{"key":"10.1378\/chest.11-2521_bib48","series-title":"PROspective multicenter imaging study for evaluation of chest pain (PROMISE). NCT01174550","author":"National Institutes of Health Clinical Center","year":"2010"},{"key":"10.1378\/chest.11-2521_bib49","series-title":"Multicenter study to rule out myocardial infarction by cardiac computed tomography (ROMICAT-II). NCT01084239","author":"National Institutes of Health Clinical Center","year":"2010"},{"issue":"8","key":"10.1378\/chest.11-2521_bib50","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jama.2009.205","article-title":"Scientific evidence underlying the ACC\/AHA clinical practice guidelines","volume":"301","author":"Tricoci","year":"2009","journal-title":"JAMA"},{"issue":"7","key":"10.1378\/chest.11-2521_bib51","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jacc.2011.03.048","article-title":"American industry and the U.S. Cardiovascular Clinical Research Enterprise an appropriate analogy?","volume":"58","author":"Califf","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"5876","key":"10.1378\/chest.11-2521_bib52","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.320.5876.600","article-title":"Medicine. A bruising battle over lung scans","volume":"320","author":"Marshall","year":"2008","journal-title":"Science"},{"issue":"5","key":"10.1378\/chest.11-2521_bib53","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"National Lung Screening Trial Research Team","year":"2011","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1378\/chest.11-2521_bib54","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1161\/CIR.0b013e31821c36ab","article-title":"Creating a 21st century global health agenda: the General Assembly of the United Nations High Level Meeting on Non-Communicable Diseases","volume":"123","author":"Partridge","year":"2011","journal-title":"Circulation"},{"issue":"3","key":"10.1378\/chest.11-2521_bib55","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/CIRCULATIONAHA.111.018820","article-title":"Global variation in the relative burden of stroke and ischemic heart disease","volume":"124","author":"Kim","year":"2011","journal-title":"Circulation"},{"issue":"8","key":"10.1378\/chest.11-2521_bib56","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJMsb0803929","article-title":"Ethical and scientific implications of the globalization of clinical research","volume":"360","author":"Glickman","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.11-2521_bib57","series-title":"The Wisdom of the Sands","first-page":"155","author":"de Saint-Exup\u00e9ry","year":"1950"},{"key":"10.1378\/chest.11-2521_bib58","doi-asserted-by":"crossref","unstructured":"Shurin SB. Funding mechanisms and program management at the National Heart, Lung, and Blood Institute (NHLBI): confronting new challenges and exploring new opportunities [published online ahead of print August 25, 2011]. Blood; doi:10.1182\/blood-2011-08-372367","DOI":"10.1182\/blood-2011-08-372367"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212600907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369212600907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:28:13Z","timestamp":1757917693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369212600907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0012369212600907"],"URL":"https:\/\/doi.org\/10.1378\/chest.11-2521","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing Cardiovascular Research","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.11-2521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}